Furthermore, the effects of CCL2 inhibition with a CCL2-neutralizing antibody or RNA interference (RNAi) technology on LNMAT1-induced LN metastasis were determined in vivo. This evidence concerns the gene DUXAP9 and lobular neoplasia.